135 results
Page 2 of 7
424B5
910zl
16 Feb 21
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
jyc1jmr uh
28 Dec 20
Anavex Life Sciences Reports Fiscal 2020 Year End Financial Results
5:28pm
8-K
EX-99.1
6bolq2drnu d1o4rfyuh
15 Dec 20
Primary safety, pharmacokinetics and secondary efficacy endpoints met, with consistent improvements in RSBQ Total scores and CGI-I
7:06am
8-K
EX-99.1
hbuvmi5
6 Nov 20
Other Events
11:15am
8-K
EX-99.1
kfuk8mvp23o9
15 Oct 20
Regulation FD Disclosure
7:02am
424B5
x71wy
2 Jul 20
Prospectus supplement for primary offering
5:23pm
424B5
1wamfg pvs1p8
1 May 20
Prospectus supplement for primary offering
7:06am
424B5
bwg4r7z y7703qghyh6
1 May 20
Prospectus supplement for primary offering
7:01am
424B5
h2qy1v np
13 Sep 19
Prospectus supplement for primary offering
5:06pm
424B5
nbjgiflpfxz6un
12 Jun 19
Prospectus supplement for primary offering
5:01pm
424B5
wcbc5mjtu379dcuo
18 Mar 19
Prospectus supplement for primary offering
12:00am